)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Bio-Techne
Bio-Techne (TECH) investor relations material
Bio-Techne 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary13 Jan, 2026
Company overview and financial performance
Operates in two segments: protein sciences and diagnostics/spatial biology, with 3,100 employees across 34 locations and $1.2B in 2025 revenue.
81% of revenue comes from consumables, 73% from protein sciences, and 27% from diagnostics/spatial biology.
Biopharma is the largest customer segment (51%), followed by academia (20%), diagnostics (16%), and distributors (13%).
Geographic revenue split: 58% Americas, 15% APAC (including China), 27% Europe.
Achieved 10% CAGR over five years despite industry headwinds, with 5% organic growth in 2025 and 9% profitability.
Strategic focus and market positioning
Built a differentiated portfolio for established and emerging applications, leveraging protein and antibody content.
Focuses on three growth verticals: discovery, advanced therapeutics (especially cell therapy), and precision diagnostics.
Addressing a $27B total addressable market, with high single-digit growth potential.
Maintains industry-leading operating margins (35–40%) through a high-value portfolio and lean structure.
Innovation and M&A are core to growth strategy, targeting cell therapy, organoids, proteomic instrumentation, and core portfolio expansion.
Key growth applications and innovation
Cell therapy: $80M business, with GMP proteins as a core driver; two major customers received fast-track FDA designation, creating short-term headwinds but significant long-term potential.
Proteomic analytical instrumentation: 8,000-instrument install base, with platforms like Simple Western, Ella, and Maurice driving growth and AI-enabled data.
Spatial biology: $5B market, with RNAscope and COMET platforms enabling multi-omic analysis and strong consumable pull-through.
Ongoing launches include AI-designed proteins, ProPak cytokine delivery, ultra-sensitive immunoassays, and new diagnostic tools.
R&D investment at 8% of revenue, with a pipeline of transformative products targeting neuro, inflammation, and molecular diagnostics.
Cell therapy air pocket duration
China growth drivers beyond short-term
M&A focus areas and criteria
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Bio-Techne earnings date
Q2 20264 Feb, 2026
Bio-Techne
Next Bio-Techne earnings date
Q2 20264 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Bio-Techne Corporation develops, manufactures, and sells life sciences research and clinical diagnostic products. The company’s portfolio includes proteins, antibodies, reagents, and diagnostic instruments supporting academic research, biopharmaceutical production, and clinical testing. Bio-Techne serves scientists and healthcare providers globally. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage